Rainer Voegeli was added as chief business officer and head of business development and marketing

Hemispherx Biopharma Inc., of Philadelphia, appointed Jack Gwaltney and James Rahal to its scientific advisory board...Inovio AS, of Oslo, Norway, appointed David Pyrce chief business officer

and Janice Mallison vice president, clinical and regulatory affairs...Senomyx Inc., of La Jolla, Calif., added John Poyhonen as vice president and chief business officer

Ariad Pharmaceuticals Inc., of Cambridge, Mass., appointed Paul Sekhri president and chief business officer, Timothy Clackson chief scientific officer, John Iuliucci chief development officer and Tomi Sawyer senior vice president, drug discovery

Active Pass Pharmaceuticals, of Vancouver, British Columbia, appointed Jeff Tomlinson chief business officer...Apax Partners, of London, appointed David U'Prichard venture partner and Khawar Mann a member of its health care team

CytoGenix Inc., of Houston, added Cy Stein and Raymond Ocampo to its board...GlycoMimetics Inc., of Rockville, Md., appointed Franklin Top and John Baldwin to its board...It also named Jeremy Reffin and Sven Warnaar members of the board

Cytogen Corp., of Princeton, N.J., added Christopher Schnittker as vice president and chief financial officer...Incyte Corp., of Palo Alto, Calif., appointed John Keller executive vice president and chief business officer

Chiron Corp., of Emeryville, Calif., said Andrew Heaton, its vice president and chief medical officer, Chiron blood testing division, was appointed to the federal advisory committee of blood safety and availability...Evotec OAI AG, of Hamburg, Germany, appointed Bernard Questier chief business officer

Trillium Therapeutics Inc., of Toronto, appointed Elizabeth Corsi and Julia Levy to its board...Vela Pharmaceuticals Inc., of Lawrenceville, N.J., promoted Jeff Calcagno to chief business officer and Steven Leventer to senior vice president, research and development

Aradigm Corp., of Hayward, Calif., named Bryan Lawlis president and appointed Bobba Venkatadri senior vice president of operations...Phenomix Corp., of San Diego, added Chris Burnley as chief business officer and David Campbell as vice president of drug discovery

Alkermes Inc., of Cambridge, Mass., elected Gerri Henwood and Paul Mitchell to its board...Ecopia BioSciences Inc., of Montreal, appointed Gervais Dionne and Louis de Repentigny to its scientific advisory board...Paladin Labs Inc., of Montreal, appointed Aldo Baumgartner and Michael Cloutier to its board

InvestBio, of New York, appointed Ron Garren senior managing director and chief biotech strategist...PhageTech Inc., of Montreal, elected Francois Legault and Rene Kurth to its board...Sunesis Pharmaceuticals Inc., of South San Francisco, appointed Steven James chief business officer and Daniel Swisher chief operating officer

Exegenics Inc., of Dallas, elected Joseph Davie to its board and appointed David Riggs vice president, chief business officer and chief financial officer and secretary

BioXell SpA, of Milan, Italy, appointed Alex Martin chief business officer...Synbiotics Corp., of San Diego, added Paul Hays as president and chief operating officer

Array BioPharma Inc., of Boulder, Colo., appointed Gil Van Lunsen to its board, and chair of its audit committee...Avidex Ltd., of Oxford, UK, added Neill MacKenzie as chief business officer

Also, its subsidiary, SinusPharmaceuticals Research Corp., added Kimberly Halaburka as general manager and vice president, product development and clinical affairs...Xantos Biomedicine AG , of Martinsried, Germany, added David Chilvers as chief business officer

Inc., of Montgomery, Texas, appointed Kenneth Reilly, Kenneth Beverly, James Davidson and Frank Bagrier to its audit and compensation committees...EraGen Biosciences Inc., of Madison, Wis., appointed Samraat Raha chief business officer

Elixir Pharmaceuticals Inc., of Cambridge, Mass., appointed Alan Watson chief business officer and executive vice president...InterMune Inc., of Brisbane, Calif., added William Ringo and William Halter to its board

Evotec OAI AG, of Hamburg, Germany, said it is adding John Kemp as CEO of Evotec Neurosciences GmbH and promoting Sean Marett to chief business officer and member of the management board...GenStar Therapeutics Corp., of San Diego, appointed Creighton Lawhead senior vice president and chief business officer